Optimal Use of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Patients Undergoing Percutaneous Coronary Interventions

Author： Starnes H. Benjamin Patel Ankit A. Stouffer George A.

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.15, 2011-10, pp. : 2009-2030

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet Glycoprotein IIb/IIIa Receptor Antagonists And Their Use In Elderly Patients

By Mak K-H.

Drugs & Aging, Vol. 16, Iss. 3, 2000-03 ,pp. : 179-187

Adis International

Access to resources Recommend Favorite

The use of glycoprotein IIb/IIIa receptor antagonists in percutaneous coronary intervention results in both short- and long-term benefits

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 20, Iss. 10, 2004-10 ,pp. : 7-10

Adis International

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Antagonists: A Comparative Review of Their Use in Percutaneous Coronary Intervention

By Nguyen C.M. Harrington R.A.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 6, 2003-01 ,pp. : 423-436

Adis International

Access to resources Recommend Favorite

Platelet glycoprotein IIb/IIIa receptor antagonists

By Casserly I.P. Moliterno D.J.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 419-433

Informa Healthcare

Access to resources Recommend Favorite

Platelet glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions: a pharmacological and clinical review

By Anne Ganeshkumar Gruberg Luis

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 335-348

Informa Healthcare

Access to resources Recommend Favorite